Skip to Content

← See all Tolnaftate brands

Tolnaftate by Chain Drug Consortium, LLC

Dosage form: aerosol, spray
Ingredients: TOLNAFTATE 0.13g in 130g
Labeler: Chain Drug Consortium, LLC
NDC Code: 68016-536

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Jock Itch Spray

Active ingredient

Tolnaftate 1%



  • cures most jock itch (tinea cruris)
  • relieves symptoms of jock itch including itching, burning and chafing


For external use only.


Do not use while smoking or near heat or flame. Do not puncture or incinerate. Contents under pressure. Do not store at temperature above 120ºF.

When using this product
  • do not get into eyes or mouth
  • use only as directed

Intentional misuse by deliberately concentrating and inhaling contents cans be harmful or fatal.

Stop use and ask a doctor if
  • irritation occurs
  • no improvement within 2 weeks

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away. Do not use on children under 2 years of age unless directed by a doctor.

  • wash affected area and dry thoroughly
  • shake can well and spray a thin layer over affected area twice daily (morning and night)
  • supervise children in the use of this product
  • use daily for 2 weeks; if conditions persist, consult a doctor
  • in case of clogging, clear nozzle under running water

Other information

store between 20º and 30ºC (68ºF and 86º)

Inactive ingredient

BHT, isobutane (propellent), PPG-12-buteth-16, SD alcohol 40-B (14%w/w), talc


Call 1-866-964-0939

Principal Display Panel

Premier Value


Jock Itch Spray

Tolnaftate 1%

Antifungal Powder Spray

  • Cures most Symptoms of Jock Itch
  • Reliever itching, chafing, and burning

Net Wt. 4.6 OZ (130g)

jock itch spray aerosol, spray
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-536
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Inactive Ingredients
Ingredient NameStrength
#Item CodePackage Description
1NDC:68016-536-04130 g in 1 CAN
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333C04/23/2004
Labeler - Chain Drug Consortium, LLC (101668460)

Chain Drug Consortium, LLC

← See all Tolnaftate brands

Medically reviewed on Feb 5, 2018

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.